common reactions include transient pain, erythema, or pruritus at the administration site, along with mild diarrhea, headache, or nausea in a minority of recipients
The typical patient profile includes competitive athletes managing overuse injuries, post-surgical patients seeking to augment standard rehabilitation, and individuals with chronic tendinopathies unresponsive to physical therapy alone
[1] Liposomal technology directly addresses the absorption barrier
Farhadi A, Fields JZ, Keshavarzian A
Standard oral versions often fail to survive the digestive process
Further reading [edit] al